GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

Published Date: 12 Nov 2025

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists—the class of drugs behind Ozempic, Wegovy and Mounjaro, for example—may do more than regulate ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast cancer: A new target to eliminate dormant cells before they wake

2.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

3.

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

4.

Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity

5.

A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot